465 related articles for article (PubMed ID: 24308816)
1. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
[TBL] [Abstract][Full Text] [Related]
2. Episodic nature of symptoms in irritable bowel syndrome.
Palsson OS; Baggish J; Whitehead WE
Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
[TBL] [Abstract][Full Text] [Related]
3. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.
Heidelbaugh JJ; Stelwagon M; Miller SA; Shea EP; Chey WD
Am J Gastroenterol; 2015 Apr; 110(4):580-7. PubMed ID: 25781368
[TBL] [Abstract][Full Text] [Related]
5. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
7. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
Palsson OS; Baggish JS; Turner MJ; Whitehead WE
Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
[TBL] [Abstract][Full Text] [Related]
8. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
[TBL] [Abstract][Full Text] [Related]
9. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
Koloski NA; Jones M; Young M; Talley NJ
Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
[TBL] [Abstract][Full Text] [Related]
12. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
Su AM; Shih W; Presson AP; Chang L
Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.
Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
Aliment Pharmacol Ther; 2015 Mar; 41(5):449-58. PubMed ID: 25586008
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.
Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
Scand J Gastroenterol; 2015 Jul; 50(7):816-23. PubMed ID: 25636675
[TBL] [Abstract][Full Text] [Related]
15. Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study.
Shah ED; Almario CV; Spiegel BM; Chey WD
Am J Gastroenterol; 2020 Feb; 115(2):294-301. PubMed ID: 31913193
[TBL] [Abstract][Full Text] [Related]
16. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
17. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
Bouchoucha M; Devroede G; Mary F; Bon C; Bejou B; Benamouzig R
Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
[TBL] [Abstract][Full Text] [Related]
18. Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran.
Roshandel D; Rezailashkajani M; Shafaee S; Zali MR
Int J Colorectal Dis; 2006 Dec; 21(8):814-25. PubMed ID: 16565819
[TBL] [Abstract][Full Text] [Related]
19. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
Black CJ; Yiannakou Y; Houghton LA; Ford AC
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
